bmiMD review
Transparent prices, fabricated clock
The most route options and the clearest dose disclosure on the board, sold under a countdown timer that restarts for every visitor.
Our verdict
bmiMD does two things better than almost anyone on this board and one thing worse. It sells sermorelin in three routes and NAD⁺ in two, publishes every price without a signup gate, states the total charge for each tier rather than hiding a lump sum behind a monthly figure, and tells you exactly how much peptide is in the vial. Then it puts a fake countdown clock next to all of it. The pricing is honest; the urgency around it is manufactured, and we can prove that from the page source.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ injection $119/mo month-to-month down to $89/mo billed $1,068 for twelve months; nasal spray $129 down to $99 — all closeout pricing the site says ends 4 August 2026
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- Claims all 50 — confirm yours
- LegitScript
- Certified
- Updated
- August 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
A WordPress-based telehealth storefront selling compounded medications across four goal categories — weight loss, mood and energy, strength and cardio, and anti-aging. The catalogue is sermorelin (injection, oral tablet and nasal spray), NAD⁺ (injection and nasal spray), glutathione injection, a MIC plus vitamin B12 lipotropic injection, compounded semaglutide and tirzepatide including microdose protocols, metformin, and a naltrexone-bupropion-B6 combination. There is no testosterone in any form, no enclomiphene and no hormone category at all, which is why bmiMD appears on the peptide and NAD⁺ boards here and not on the TRT board.
How it works
Asynchronous-first telehealth with no in-person option. The stated flow is to place an order, complete an online medical questionnaire, receive a same-day telehealth consultation with a board-certified provider, and have medication shipped in three to five business days. Unlimited provider messaging, monthly check-ins and 24/7 support are included, and the site offers a full refund if you are not eligible for the program. Prices are entirely public before you create an account, which is more than most of this board manages and makes bmiMD genuinely easy to comparison-shop. What is not disclosed matters too: no compounding pharmacy is named, only "licensed sterile compounding pharmacies throughout the United States" with no 503A or 503B distinction; no medical director or individual clinician is named anywhere; and no corporate entity appears in the footer, which carries only a copyright line with no company name or address. Coverage is stated as all 50 states with no exclusion list published — treat that as a claim rather than a fact and confirm your own state before ordering, because compounded sermorelin availability is genuinely state-restricted for other providers on this board (Maximus, for instance, publicly excludes Alabama), and bmiMD publishes no exclusions at all.
Pricing transparency
Genuinely transparent in structure and genuinely time-limited in substance. Each product carries a plan picker where every tier is a real recurring monthly rate and the site states the upfront total in plain language — sermorelin injection at $139 a month month-to-month, $119 on three months billed $357, or $99 on six months billed $594; NAD⁺ injection at $119 month-to-month down to $89 on twelve months billed $1,068; the NAD⁺ nasal spray $129 down to $99; glutathione $119 down to $89. Naming the total is better practice than the monthly-figure-only presentation used by most competitors here. Two caveats decide how you should use these numbers. First, every figure is "Summer Closeout" pricing that bmiMD's own copy says expires on 4 August 2026, with a stated price-freeze mechanic for anyone who joins before then — so treat all of it as a snapshot and re-check before buying. That is why the cards carry no monthly floor. Second, the sermorelin marketing page contradicts itself: its plan picker sells the quarterly tier at $119 a month while a block further down the same page reads "Start for $133/month. Billed quarterly." The $119 matches every other surface on the site, including the roll-up sale page, so $133 appears to be stale copy. Do not use it.
Branded vs compounded
Compounded; not FDA-approved — and bmiMD says so itself, which deserves credit on a board where several competitors say nothing at all. Its FAQ states that its formulations are not FDA-approved but are made from pharmaceutical-grade ingredients, it carries a proper compounded-medication disclaimer describing the state-licensed or FDA-registered compounding facility, and it correctly caveats that its compounded microdose formulations have not been specifically studied for the effects it markets them for. On the evidence, the two headline lines sit at different tiers. Sermorelin is a GHRH analogue that prompts your own pituitary to release growth hormone rather than supplying it, preserving the feedback loop that exogenous growth hormone overrides — a real, well-characterised mechanism whose long-term human outcome data stays thin beyond short-term IGF-1 movement. Injected and intranasal NAD⁺ have no controlled human outcome trials; the NAD⁺ forms with human trial data are the oral precursors nicotinamide riboside and nicotinamide mononucleotide, which raise a blood level rather than demonstrate an outcome. Glutathione has essentially no controlled human outcome data. Individual results vary.
Pros and watch-outs
What we like
- Sermorelin in three routes and NAD⁺ in two, each separately priced — the widest route coverage in this group
- Full dose disclosure on the sermorelin injection: 5 mL vial at 2 mg/mL, 10 mg a month, roughly thirty injections
- Every price public with no signup gate, and the upfront total stated for each multi-month tier
- States plainly that its compounded formulations are not FDA-approved, and that microdose protocols have not been specifically studied
- Discloses that program cost includes the medication and that no membership fee sits underneath
Watch-outs
- The countdown timer beside the prices is fabricated — the page source sets it with the comment "always start at 15 mins", so it restarts on every page load for every visitor
- All pricing is closeout pricing the site says expires 4 August 2026, so any figure quoted has a short shelf life
- The sermorelin page states two different quarterly prices, $119 in the plan picker and $133 further down the same page
- A "5,489 new members" figure presented as a live statistic is hardcoded text, not a counter
- No compounding pharmacy, medical director, clinician or corporate entity is named anywhere
- A Forbes Health logo sits under "As seen on" with an empty alt attribute and no link to any article, beside a set of ad landing pages named after the same publications
Best for
Anyone comparing sermorelin or NAD⁺ across delivery routes who wants the dose stated and will verify the price on the day they buy.
Who should look elsewhere
Anyone who wants testosterone — bmiMD sells none — or who needs a named prescriber, a named pharmacy or a price they can rely on past early August.
The evidence behind what bmiMD prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- Sermorelin cost in 2026: per-month pricing, the intro-vs-renewal trap, and what your subscription buys
Compounded sermorelin is cash-pay and sold by subscription — roughly $120–$200/month once the intro rate steps up. Here’s a provider-by-provider price comparison, injection vs oral, and how to read a plan on a true per-month basis.
- NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How bmiMD compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak Longevity
Low-cost sermorelin within a broader longevity stack
See Oak Longevity → - HealthRX
Compounded sermorelin within a broad longevity and weight-care menu
See HealthRX → - Bodybuilding Health+
Pairing sermorelin with a strength-training and recovery focus
See Bodybuilding Health+ →
Access & cost · Reviewed and last verified August 2026
How we assessed this. This review reflects Aminoscope’s own read of bmiMD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is bmiMD's countdown timer real?
- No. The live page source sets the clock with the comment "always start at 15 mins (900 seconds)", so it restarts at fifteen minutes for every visitor on every page load. It is not tied to the 4 August date the rest of the site cites for its closeout. The underlying deadline may well be real; the clock in front of it is not.
- Does bmiMD offer testosterone or TRT?
- No. Its entire catalogue is GLP-1 medications, metformin, a naltrexone-bupropion combination, MIC plus B12, sermorelin, NAD⁺ and glutathione. There is no testosterone, no enclomiphene and no hormone category, which is why it does not appear on our TRT board.
- What is the actual price of sermorelin at bmiMD?
- As read on 1 August 2026: $139 a month month-to-month, $119 a month on a three-month plan billed $357 upfront, or $99 a month on a six-month plan billed $594 upfront. All of those are closeout figures the site says end on 4 August 2026. One block on the sermorelin page says "$133/month, billed quarterly", which contradicts the $119 shown in the plan picker and on every other page — treat $133 as stale.
- How much sermorelin do you actually get?
- bmiMD is unusually specific: the injection is a 5 mL vial at 2 mg/mL, which is 10 mg a month and roughly thirty injections. That matters when comparing against providers whose vials differ — one competitor on this board ships 15 mg a month at a higher headline price, which is closer to parity per milligram than the headline suggests.